The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Signaling Mechanisms That Regulate Glucose Transport
Open accessAbstract
phosphotyrosine-binding Pleckstrin homology Src homology 2 phosphatidylinositol insulin-like growth factor platelet-derived growth factor 5′-AMP-activated protein kinase. Insulin, the major hormonal regulator of glucose transport in humans, has served as a prototypic molecule for understanding cell signaling pathways since its discovery in 1922. It was among the first proteins for which primary amino acid sequence and three-dimensional structure were determined. The insulin receptor was likewise among the first peptide receptors to be identified by ligand binding, and its subunit structure was deduced in the earliest days of modern receptor biology (1Massague J. Pilch P.F. Czech M.P. Proc. Natl. Acad. Sci. U. S. A. 1980; 77: 7137-7141Crossref PubMed Scopus (161) Google Scholar). The structure of its tyrosine kinase domain was the first of the tyrosine kinases to be solved by x-ray crystallography (2Hubbard S.R. EMBO J. 1997; 16: 5572-5581Crossref PubMed Scopus (769) Google Scholar). Further, much is now known about downstream insulin receptor signaling components (3Avruch J. Mol. Cell. Biochem. 1998; 182: 31-48Crossref PubMed Scopus (319) Google Scholar). Despite these advances, our understanding of how insulin and the related proteins, insulin-like growth factors I and II, stimulate glucose transport (via the translocation of glucose transporter proteins from intracellular to plasma membranes) is fragmentary. One reason for this is that the major target for insulin signaling to glucose transport is a complex membrane trafficking pathway that is likely to contain many unknown components. As summarized in the preceding introductory comments (4Olefsky J.M. J. Biol. Chem. 1999; 274: 1863Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar) and detailed in the companion minireviews to be published subsequently (5Pessin J.E. Thurmond D.C. Elmendorf J.S. Coker K.J. Okada S. J. Biol. Chem. 1999; 274: 2593-2596Abstract Full Text Full Text PDF PubMed Scopus (348) Google Scholar, 6Charron M.J. Katz E.B. Olson A.L. J. Biol. Chem. 1999; 274: 3253-3256Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar), glucose uptake via the GLUT4 isoform of mammalian hexose transporters accounts for most of the stimulatory effect of insulin on this process in muscle and fat cells. GLUT4 rapidly recycles through the plasma membrane/endosomal membrane system in the presence of insulin. However, in the basal state this transporter protein is directed to and retained within specific intracellular membranes through the action of distinct elements within the GLUT4 structure (7Corvera S. Czech M.P. Cell. Dev. Biol. 1996; 7: 249-257Crossref Scopus (5) Google Scholar). Insulin causes movement of GLUT4 out of this sequestered localization, leading to an increase in its steady state concentration on the cell surface membrane where it can catalyze glucose uptake. However, to accomplish this, insulin signaling is likely to regulate GLUT4 trafficking at multiple steps, consistent with data showing insulin also enhances cell surface display of proteins such as transferrin receptor and GLUT1 that recycle to a large extent independently of GLUT4. To further complicate our understanding of this system, different signaling elements may be required to modulate each of these different putative regulated steps in the GLUT4 trafficking pathway. Substrate phosphorylation by the insulin receptor tyrosine kinase appears to involve the binding of phosphorylated receptor tyrosine 960 to phosphotyrosine-binding (PTB)1 domains of substrate proteins (8White M.F. Mol. Cell. Biochem. 1998; 182: 3-11Crossref PubMed Scopus (622) Google Scholar). Adjacent Pleckstrin homology (PH) domains on some substrate proteins also appear critical for receptor binding and phosphorylation. Tyrosine kinase signaling is often initiated by the recruitment of signaling proteins through their Src homology 2 (SH2) or PTB domains to phosphotyrosine sites. In the case of insulin receptor, tyrosine phosphorylation of four related substrate (IRS) proteins (8White M.F. Mol. Cell. Biochem. 1998; 182: 3-11Crossref PubMed Scopus (622) Google Scholar) and Gab-1 (9Rocci S. Tartare-Deckert S. Murdaca J. Wong A.J. Van Obberghen E. Mol. Endocrinol. 1998; 12: 914-923Crossref PubMed Scopus (65) Google Scholar) causes many candidate signaling proteins to be recruited, including: 1) the p110-type phosphatidylinositol 3-kinase (PI 3-kinase) through the SH2 domains of p85 regulatory subunits; 2) Grb2 and the protein tyrosine phosphatase SH-PTP2, which appear to be necessary for p21ras activation (10Pawson T. Nature. 1995; 373: 573-580Crossref PubMed Scopus (2211) Google Scholar); 3) the tyrosine kinase Fyn, which in turn may also activate the PI 3-kinase and p21raspathways; and 4) Rho-associated protein serine/threonine kinase ROKα (11Farah S. Agazie Y. Ohan N. Ngsee J.K. Liu X.J. J. Biol. Chem. 1998; 273: 4740-4746Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scho
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
Tamemoto, H., Kadowaki, T., Tobe, K., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S., et al. (1994) · Nature · doi:10.1038/372182a0 · Cited by 1,083
Cheatham, B., Vlahos, C. J., Cheatham, L., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902 · Cited by 1,068
Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation
COFFER, P. J., JIN, J., & WOODGETT, J. R. (1998) · Biochemical Journal · doi:10.1042/bj3350001 · Cited by 1,067
Phosphoinositide 3-kinases: A conserved family of signal transducers
Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01061-x · Cited by 954
Hubbard, S. R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5572 · Cited by 953
Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., & Ui, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41901-6 · Cited by 918
Cited by
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Huang, S., & Czech, M. P. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.006 · Cited by 1,385
Self-citationKlaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y.-B., Sharpe, A. H., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5479-5489.2000 · Cited by 1,235
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031
Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation
Sano, H., Kane, S., Sano, E., Mı̂inea, C. P., Asara, J. M., Lane, W. S., Garner, C. W., & Lienhard, G. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300063200 · Cited by 962
Signaling pathways in insulin action: molecular targets of insulin resistance
Pessin, J. E., & Saltiel, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10582 · Cited by 939
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Mu, J., Brozinick, J. T., Valladares, O., Bucan, M., & Birnbaum, M. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00251-9 · Cited by 924
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 692
CAP defines a second signalling pathway required for insulin-stimulated glucose transport
Baumann, C. A., Ribon, V., Kanzaki, M., Thurmond, D. C., Mora, S., Shigematsu, S., Bickel, P. E., Pessin, J. E., & Saltiel, A. R. (2000) · Nature · doi:10.1038/35025089 · Cited by 661
The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor Therapy
Murata, H., Hruz, P. W., & Mueckler, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000228200 · Cited by 586
Amino Acid and Insulin Signaling via the mTOR/p70 S6 Kinase Pathway
Tremblay, F., & Marette, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106703200 · Cited by 542
Adaptation and Maladaptation of the Heart in Diabetes: Part I: General Concepts
Taegtmeyer, H., McNulty, P., & Young, M. E. (2002) · Circulation · doi:10.1161/01.cir.0000012466.50373.e8 · Cited by 521
Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms
Young, M. E., McNulty, P., & Taegtmeyer, H. (2002) · Circulation · doi:10.1161/01.cir.0000012467.61045.87 · Cited by 466
Regulated Membrane Trafficking of the Insulin-Responsive Glucose Transporter 4 in Adipocytes
Watson, R. T., Kanzaki, M., & Pessin, J. E. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0011 · Cited by 448
Overcoming anoikis – pathways to anchorage-independent growth in cancer
Guadamillas, M. C., Cerezo, A., & del Pozo, M. A. (2011) · Journal of Cell Science · doi:10.1242/jcs.072165 · Cited by 426
Haruta, T. (2000) · Molecular Endocrinology · doi:10.1210/me.14.6.783 · Cited by 419
Zinker, B. A., Rondinone, C. M., Trevillyan, J. M., Gum, R. J., Clampit, J. E., Waring, J. F., Xie, N., Wilcox, D., Jacobson, P., Frost, L., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142298199 · Cited by 414
Molecular Basis of Insulin-stimulated GLUT4 Vesicle Trafficking
Pessin, J. E., Thurmond, D. C., Elmendorf, J. S., Coker, K. J., & Okada, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2593 · Cited by 412
Cell signaling, the essential role of O-GlcNAc
Zachara, N. E., & Hart, G. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.04.007 · Cited by 386
Insulin signaling and insulin sensitivity after exercise in human skeletal muscle
Wojtaszewski, J. F., Hansen, B. F., Gade, Kiens, B., Markuns, J. F., Goodyear, L. J., & Richter, E. A. (2000) · Diabetes · doi:10.2337/diabetes.49.3.325 · Cited by 382
Jiang, Z. Y., Zhou, Q. L., Coleman, K. A., Chouinard, M., Boese, Q., & Czech, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332633100 · Cited by 378
Self-citationThe lipid phosphatase SHIP2 controls insulin sensitivity
Clément, S., Krause, U., Desmedt, F., Tanti, J.-F., Behrends, J., Pesesse, X., Sasaki, T., Penninger, J., Doherty, M., Malaisse, W., et al. (2001) · Nature · doi:10.1038/35051094 · Cited by 376
Mauney, J. R., Nguyen, T., Gillen, K., Kirker-Head, C., Gimble, J. M., & Kaplan, D. L. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.017 · Cited by 373
Falcão-Pires, I., & Leite-Moreira, A. F. (2012) · Heart Failure Reviews · doi:10.1007/s10741-011-9257-z · Cited by 363
Insulin and hyperandrogenism in women with polycystic ovary syndrome
Baptiste, C. G., Battista, M.-C., Trottier, A., & Baillargeon, J.-P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.010 · Cited by 355
Metabolic effects of indinavir in healthy HIV-seronegative men
Noor, M. A., Lo, J. C., Mulligan, K., Schwarz, J.-M., Halvorsen, R. A., Schambelan, M., & Grunfeld, C. (2001) · AIDS · doi:10.1097/00002030-200105040-00001 · Cited by 350
Rab Proteins, Connecting Transport and Vesicle Fusion
Jordens, I., Marsman, M., Kuijl, C., & Neefjes, J. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00336.x · Cited by 344
Recent Advances in Our Understanding of Insulin Action and Insulin Resistance
Le Roith, D., & Zick, Y. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.588 · Cited by 337
Lipid and lipoprotein dysregulation in insulin resistant states
Avramoglu, R. K., Basciano, H., & Adeli, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.026 · Cited by 318
Zahniser, N. R., & Doolen, S. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00158-9 · Cited by 310
Guha, M., Bai, W., Nadler, J. L., & Natarajan, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.23.17728 · Cited by 309
Skeberdis, V. A., Lan, J.-Y., Zheng, X., Zukin, R. S., & Bennett, M. V. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051634698 · Cited by 306
Pathophysiological implications of insulin resistance on vascular endothelial function
Wheatcroft, S. B., Williams, I. L., Shah, A. M., & Kearney, M. T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00869.x · Cited by 306
Tang, X.-H., & Shay, N. F. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.5.1414 · Cited by 288
Pathophysiology of insulin resistance
Sesti, G. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.09.007 · Cited by 285
Chi, N.-W., & Lodish, H. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007635200 · Cited by 277
Noor, M. A., Seneviratne, T., Aweeka, F. T., Lo, J. C., Schwarz, J.-M., Mulligan, K., Schambelan, M., & Grunfeld, C. (2002) · AIDS · doi:10.1097/00002030-200203290-00002 · Cited by 275
Bruss, M. D., Arias, E. B., Lienhard, G. E., & Cartee, G. D. (2005) · Diabetes · doi:10.2337/diabetes.54.1.41 · Cited by 273
Angiotensin II–Induced Insulin Resistance Is Associated With Enhanced Insulin Signaling
Ogihara, T., Asano, T., Ando, K., Chiba, Y., Sakoda, H., Anai, M., Shojima, N., Ono, H., Onishi, Y., Fujishiro, M., et al. (2002) · Hypertension · doi:10.1161/01.hyp.0000040262.48405.a8 · Cited by 274
PIKfyve, a Mammalian Ortholog of Yeast Fab1p Lipid Kinase, Synthesizes 5-Phosphoinositides
Sbrissa, D., Ikonomov, O. C., & Shisheva, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21589 · Cited by 271
PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity
Zhang, Z.-Y., & Lee, S.-Y. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.2.223 · Cited by 271
Glucose transporter recycling in response to insulin is facilitated by myosin Myo1c
Bose, A., Guilherme, A., Robida, S. I., Nicoloro, S. M. C., Zhou, Q. L., Jiang, Z. Y., Pomerleau, D. P., & Czech, M. P. (2002) · Nature · doi:10.1038/nature01246 · Cited by 267
Self-citationIkonomov, O. C., Sbrissa, D., & Shisheva, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101722200 · Cited by 263
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Akinleye, A., Avvaru, P., Furqan, M., Song, Y., & Liu, D. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-88 · Cited by 254
Powelka, A. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26040 · Cited by 236
Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?
Correia, S. C., Santos, R. X., Perry, G., Zhu, X., Moreira, P. I., & Smith, M. A. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.01.001 · Cited by 212
Mechanisms of Hepatic Very Low-Density Lipoprotein Overproduction in Insulin Resistance
Adeli, K., Taghibiglou, C., Van Iderstine, S. C., & Lewis, G. F. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00084-6 · Cited by 194
Fujii, N., Hirshman, M. F., Kane, E. M., Ho, R. C., Peter, L. E., Seifert, M. M., & Goodyear, L. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504208200 · Cited by 177
Ha, E., Yim, S., Chung, J., Yoon, K., Kang, I., Cho, Y. H., & Baik, H. H. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00334.x · Cited by 124
Guilherme, A., Soriano, N. A., Furcinitti, P. S., & Czech, M. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401918200 · Cited by 112
Self-citationEffect of GLP-1 on glucose transport and its cell signalling in human myocytes
González, N., Acitores, A., Sancho, V., Valverde, I., & Villanueva-Peñacarrillo, M. L. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.10.002 · Cited by 85
Wolfe, A., Divall, S., & Wu, S. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.05.007 · Cited by 83
Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle
Op ‘t Eijnde, B., Richter, E. A., Henquin, J. ‐., Kiens, B., & Hespel, P. (2001) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2001.00786.x · Cited by 79
Insulin Regulation of GnRH Gene Expression through MAP Kinase Signaling Pathways
Kim, H. H., DiVall, S. A., Deneau, R. M., & Wolfe, A. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.07.002 · Cited by 78
Metadata
- Authors
- Czech, M. P., & Corvera, S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-01
- Volume
- 274
- Issue
- 4
- Pages
- 1865-1868
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2012079492
- Cited by
- 515
- References
- 72
- FWCI
- 18.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.